Bone Marrow Findings Before and After CSA Therapy
. | Patient 1 . | Patient 2 . | Patient 3 . | |||
---|---|---|---|---|---|---|
Pre . | Post . | Pre . | Post . | Pre . | Post . | |
Cellularity (%) | 80 | 50 | 20 | 70 | 20 | 20 |
Lymphocytes (%) | 77 | 67 | 29 | 17 | 50 | 24 |
Lymphocyte mass4-150 | 62 | 34 | 12 | 6 | 10 | 5 |
Granulocytes (%) | 6 | 14 | 6 | 12 | 4 | 6 |
Granulocyte mass4-150 | 5 | 7 | 1 | 4 | 1 | 2 |
Erythroid cells (%) | 10 | 17 | 63 | 25 | 25 | 54 |
M:E ratio | 1:2 | 1:1 | 1:16 | 1:4 | 1:5 | 1:5 |
Megakaryocytes4-151 | 1 | 2 | 5 | 10 | 1 | 1 |
. | Patient 1 . | Patient 2 . | Patient 3 . | |||
---|---|---|---|---|---|---|
Pre . | Post . | Pre . | Post . | Pre . | Post . | |
Cellularity (%) | 80 | 50 | 20 | 70 | 20 | 20 |
Lymphocytes (%) | 77 | 67 | 29 | 17 | 50 | 24 |
Lymphocyte mass4-150 | 62 | 34 | 12 | 6 | 10 | 5 |
Granulocytes (%) | 6 | 14 | 6 | 12 | 4 | 6 |
Granulocyte mass4-150 | 5 | 7 | 1 | 4 | 1 | 2 |
Erythroid cells (%) | 10 | 17 | 63 | 25 | 25 | 54 |
M:E ratio | 1:2 | 1:1 | 1:16 | 1:4 | 1:5 | 1:5 |
Megakaryocytes4-151 | 1 | 2 | 5 | 10 | 1 | 1 |